SCHEMBL14113257

SCHEMBL14113257

COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)CS(=O)(=O)N2CCN(C)CC2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14113252 0.94 — —
SCHEMBL7248370 0.94 — —
SCHEMBL4904211 0.94 — —
SCHEMBL14113247 0.92 MLNR (0.53) —
SCHEMBL30585310 0.87 SPPL2A (0.54) —
SCHEMBL6102665 0.87 SPPL2A (0.54) —
SCHEMBL7954523 0.87 SPPL2A (0.54) —
SCHEMBL4913960 0.86 SPPL2A (0.53) —
SCHEMBL14113250 0.86 SPPL2A (0.53) —
SCHEMBL6262004 0.86 MLNR (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176842-A1 BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE LLC (US) 2008-07-24 — — US disclosed
US-7297793-B2 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE, LLC (US) 2007-11-20 — — US disclosed
US-7297793-B2 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE, LLC (US) 2007-11-20 — — US disclosed
Send feedback